The potential of cross-linking mass spectrometry in the development of protein-protein interaction modulators


  • M. Ruwolt
  • I. Piazza
  • F. Liu


  • Current Opinion in Structural Biology


  • Curr Opin Struct Biol 82: 102648


  • Cross-linking mass spectrometry (XL-MS) can provide a wealth of information on endogenous protein-protein interaction (PPI) networks and protein binding interfaces. These features make XL-MS an attractive tool to support the development of PPI-targeting drugs. Though not yet widely used, applications of XL-MS to drug characterization are beginning to emerge. Here, we compare XL-MS to established structural proteomics methods in drug research, discuss the current state and remaining challenges of XL-MS technology, and provide a perspective on the future role XL-MS can play in drug development, with a particular emphasis on PPI modulators.